Roberta Lanzillo Selected Research

Roberta Lanzillo Research Topics

Disease

77	Multiple Sclerosis 03/2024 - 10/2005
14	Relapsing-Remitting Multiple Sclerosis 01/2023 - 04/2010
9	Progressive Multifocal Leukoencephalopathy 07/2023 - 01/2014
7	Cognitive Dysfunction 11/2023 - 01/2017
6	Inflammation (Inflammations) 06/2023 - 01/2019
6	COVID-19 01/2023 - 10/2020
5	Infections 11/2022 - 01/2019
4	Atrophy 03/2023 - 01/2016
3	Chronic Progressive Multiple Sclerosis 04/2024 - 01/2016
3	Sudden Infant Death (SID) 01/2022 - 01/2020
2	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2023 - 07/2022
2	Neuromyelitis Optica (Devic's Disease) 11/2022 - 11/2019
2	Ganglion Cysts (Ganglion) 07/2022 - 12/2021
2	Atrioventricular Block 05/2021 - 09/2016
1	Lymphopenia (Lymphocytopenia) 11/2023
1	HIV Infections (HIV Infection) 07/2023
1	Obesity 06/2023
1	Congenital Abnormalities (Deformity) 01/2023
1	Exanthema (Rash) 12/2022
1	Substance-Related Disorders (Drug Abuse) 12/2022
1	Dyspnea (Shortness of Breath) 12/2022
1	Tachycardia (Tachyarrhythmias) 12/2022
1	Conjunctivitis 12/2022
1	Chest Pain (Chest Pains) 12/2022
1	Optic Neuritis (Retrobulbar Neuritis) 11/2022
1	Radiculopathy (Radiculopathy, Cervical) 11/2022
1	Myelitis 11/2022
1	Demyelinating Diseases (Demyelinating Disease) 11/2022
1	Breakthrough Infections 11/2022
1	Glaucoma 07/2022
1	Communicable Diseases (Infectious Diseases) 07/2022
1	Bradycardia 05/2021
1	Starvation 01/2021
1	Virus Diseases (Viral Diseases) 11/2019
1	Bacterial Infections (Bacterial Infection) 11/2019
1	Pneumonia (Pneumonitis) 01/2019
1	Fatigue 01/2019
1	Bacterial Pneumonia 01/2019

Drug/Important Bio-Agent (IBA)

15	Natalizumab (Tysabri)FDA Link 07/2023 - 01/2014
10	Biomarkers (Surrogate Marker)IBA 08/2022 - 01/2014
9	ocrelizumabIBA 03/2024 - 11/2019
9	AntibodiesIBA 11/2022 - 10/2005
7	Monoclonal AntibodiesIBA 01/2023 - 01/2019
6	Retinaldehyde (Retinal)IBA 01/2023 - 11/2018
6	Rituximab (Mabthera)FDA Link 11/2022 - 11/2019
5	Fingolimod Hydrochloride (FTY720)FDA Link 11/2023 - 09/2016
5	Interferon-betaIBA 01/2023 - 08/2015
5	InterferonsIBA 01/2018 - 06/2006
4	COVID-19 VaccinesIBA 11/2023 - 01/2022
4	Cladribine FDA LinkGeneric 01/2022 - 01/2020
4	Interferon beta-1a FDA Link 11/2021 - 04/2010
3	Proteins (Proteins, Gene)FDA Link 06/2023 - 10/2019
3	Dimethyl FumarateIBA 01/2023 - 04/2021
3	Immunoglobulin M (IgM)IBA 01/2022 - 10/2005
3	Atorvastatin (Lipitor)FDA Link 02/2019 - 04/2010
2	SphingosineIBA 11/2023 - 01/2022
2	Vitamin D FDA LinkGeneric 11/2023 - 06/2023
2	AntioxidantsIBA 06/2023 - 11/2021
2	IronIBA 03/2023 - 03/2023
2	Immunoglobulins (Immunoglobulin)IBA 01/2023 - 01/2022
2	nitazoxanide (NTZ)FDA Link 09/2022 - 01/2021
2	AntigensIBA 07/2022 - 11/2019
2	Peptides (Polypeptides)IBA 01/2022 - 07/2020
2	EpitopesIBA 01/2022 - 07/2020
2	Immunoglobulin G (IgG)IBA 12/2020 - 10/2005
2	CannabidiolIBA 10/2020 - 01/2020
2	Dronabinol (THC)FDA LinkGeneric 10/2020 - 01/2020
2	nabiximols (Sativex)IBA 06/2020 - 01/2020
2	Alemtuzumab (Campath)FDA Link 11/2019 - 01/2019
2	coenzyme Q10 (CoQ10)IBA 09/2019 - 01/2019
2	GadoliniumIBA 02/2019 - 12/2016
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2016 - 04/2010
2	Uric Acid (Urate)IBA 04/2015 - 01/2015
1	siponimodIBA 04/2024
1	ozanimodIBA 11/2023
1	Hormones (Hormone)IBA 10/2023
1	SugarsIBA 06/2023
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 06/2023
1	Methylprednisolone FDA LinkGeneric 01/2023
1	SmokeIBA 12/2022
1	Myelin-Oligodendrocyte GlycoproteinIBA 11/2022
1	Botulinum Toxins (Botulinum Toxin)IBA 11/2022
1	N-acetyltalosaminuronic acid (NAT)IBA 11/2022
1	Phosphates (Orthophosphate)IBA 01/2022
1	Myelin Basic ProteinIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	AutoantibodiesIBA 01/2022
1	PhytochemicalsIBA 11/2021
1	CurcuminIBA 11/2021
1	Neuroprotective AgentsIBA 11/2021
1	Potassium Channels (Potassium Channel)IBA 05/2021
1	GTP-Binding Proteins (G-Protein)IBA 05/2021
1	Amino Acid Transport Systems (Amino Acid Transporter)IBA 01/2021
1	Cytidine Diphosphate (CDP)IBA 07/2020
1	Surface Antigens (Surface Antigen)IBA 11/2019
1	Annexin A1IBA 10/2019
1	GlucocorticoidsIBA 10/2019

Therapy/Procedure

20	Therapeutics 11/2023 - 04/2010
2	Injections 11/2022 - 05/2018
2	Cognitive Training 02/2022 - 01/2018